Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  12/31/1969
New England Retina Associates
mi
from
New London, CT
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
New England Retina Associates
mi
from
New London, CT
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  12/31/1969
Florida Eye Clinic
mi
from
Altamonte Springs, FL
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Florida Eye Clinic
mi
from
Altamonte Springs, FL
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  12/31/1969
Retina Specialty Institute
mi
from
Pensacola, FL
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Retina Specialty Institute
mi
from
Pensacola, FL
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  12/31/1969
Center for Retina and Macular Disease
mi
from
Winter Haven, FL
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Center for Retina and Macular Disease
mi
from
Winter Haven, FL
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  12/31/1969
Wilmer Eye Institute at John Hopkins University
mi
from
Baltimore, MD
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Wilmer Eye Institute at John Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  12/31/1969
TLC Eye Group
mi
from
Jackson, MI
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
TLC Eye Group
mi
from
Jackson, MI
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  12/31/1969
Island Retina
mi
from
Shirley, NY
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Island Retina
mi
from
Shirley, NY
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  12/31/1969
Charlotte EENT Associates
mi
from
Charlotte, NC
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Charlotte EENT Associates
mi
from
Charlotte, NC
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  12/31/1969
Black Hills Regional Eye Institute
mi
from
Rapid City, SD
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Black Hills Regional Eye Institute
mi
from
Rapid City, SD
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  12/31/1969
Austin Retina Associates
mi
from
Austin, TX
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Austin Retina Associates
mi
from
Austin, TX
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  12/31/1969
Retina Consultant of Houston
mi
from
Houston, TX
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Retina Consultant of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  12/31/1969
Spokane Eye Clinical Research
mi
from
Spokane, WA
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Spokane Eye Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated:  12/31/1969
Associated Retina Consultants
mi
from
Phoenix, AZ
Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema
A Phase 2 Randomized, Controlled, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of Luminate® (ALG-1001) as Compared to Avastin® in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 12/31/1969
Associated Retina Consultants
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Remifentanil and Glycemic Response in Cardiac Surgery
The Effect of Intraoperative Continuous Remifentanil Infusion on Glycemic Response and Variability in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Prospective, Randomized, Open Label Clinical Trial
Status: Enrolling
Updated:  12/31/1969
UPMC Presbyterian Hospital
mi
from
Pittsburgh, PA
Remifentanil and Glycemic Response in Cardiac Surgery
The Effect of Intraoperative Continuous Remifentanil Infusion on Glycemic Response and Variability in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Prospective, Randomized, Open Label Clinical Trial
Status: Enrolling
Updated: 12/31/1969
UPMC Presbyterian Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
Status: Enrolling
Updated:  12/31/1969
Meriter Wisconsin Heart
mi
from
Madison, WI
A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
Status: Enrolling
Updated: 12/31/1969
Meriter Wisconsin Heart
mi
from
Madison, WI
Click here to add this to my saved trials
A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
Status: Enrolling
Updated:  12/31/1969
University of Colorado
mi
from
Aurora, CO
A Rollover Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
Status: Enrolling
Updated: 12/31/1969
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of Alabama
mi
from
Birmingham, AL
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of Arizona
mi
from
Tucson, AZ
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Los Angeles Medical Center
mi
from
Los Angeles, CA
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Los Angeles Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of Southern California
mi
from
Los Angeles, CA
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Valley Children's Hospital
mi
from
Madera, CA
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Valley Children's Hospital
mi
from
Madera, CA
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Rady Children's Hospital
mi
from
San Diego, CA
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Rady Children's Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Nemours/Alfred I. duPont Hospital for Children
mi
from
Wilmington, DE
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Nemours/Alfred I. duPont Hospital for Children
mi
from
Wilmington, DE
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Childrens National Medical Center
mi
from
Washington,
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Clearwater Cardiovascular Consultants
mi
from
Clearwater, FL
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Clearwater Cardiovascular Consultants
mi
from
Clearwater, FL
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Baptist Medical Center
mi
from
Jacksonville, FL
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Baptist Medical Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Florida Hospital Orlando
mi
from
Orlando, FL
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Florida Hospital Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Arnold Palmer Hospital for Children
mi
from
Orlando, FL
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Arnold Palmer Hospital for Children
mi
from
Orlando, FL
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Tampa General Hospital
mi
from
Tampa, FL
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Advocate Christ Medical Center
mi
from
Oak Lawn, IL
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Advocate Christ Medical Center
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Riley Hospital for Children
mi
from
Indianapolis, IN
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Iowa Heart Center / Mercy Medical Center
mi
from
West Des Moines, IA
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Iowa Heart Center / Mercy Medical Center
mi
from
West Des Moines, IA
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Children's Hospital
mi
from
New Orleans, LA
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Children's Hospital
mi
from
New Orleans, LA
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Michigan
mi
from
Detroit, MI
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Michigan
mi
from
Detroit, MI
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Children's Hospitals and Clinics of Minnesota
mi
from
Minneapolis, MN
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Children's Hospitals and Clinics of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
University of Mississippi Medical Center
mi
from
Jackson, MS
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Albany Medical College
mi
from
Albany, NY
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Cohen Children's Medical Center
mi
from
New Hyde Park, NY
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Cohen Children's Medical Center
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
New York Presbyterian/Cornell
mi
from
New York, NY
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
New York Presbyterian/Cornell
mi
from
New York, NY
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Children's Hospital New York-Presbyterian
mi
from
New York, NY
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Children's Hospital New York-Presbyterian
mi
from
New York, NY
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated:  12/31/1969
Duke University Hospital
mi
from
Durham, NC
ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study
Closure of Atrial Septal Defects With the AMPLATZER™ Septal Occluder (ASO) Post Market Surveillance Study
Status: Enrolling
Updated: 12/31/1969
Duke University Hospital
mi
from
Durham, NC
Click here to add this to my saved trials